by Instem Team | Aug 13, 2025 | Clinical
Clinical trials today are a beast. Data arrives from dozens of sites, in chunks and streams: EDC records, lab values, imaging files, device signals, wearables, electronic health records. This growth in volume and complexity strains legacy systems and life sciences...
by Instem Team | Aug 12, 2025 | Regulatory Submission, SEND
Organizing and preparing research datasets for regulatory compliance can be a complex and time-consuming challenge. The life science industry’s Standard for Exchange of Nonclinical Data (SEND) initiative sets out detailed guidance to standardize the organization and...
by Instem Team | Aug 7, 2025 | Regulatory Submission, Resources, SEND
SEND-format data is a required submission standard, but practically, what else can we do with highly formatted and controlled datasets? The industry’s universal adoption of standardization and quest for improvement opens the door to exciting, innovative...
by Instem Team | Jul 31, 2025 | Company News, Press Releases, Pristima, Study Management
31 July 2025 – Boston, MA; Staffordshire, UK, Instem today announced the closing of an acquisition of Xybion Digital (“Xybion”). Xybion is best known for its Pristima™ preclinical study management platform. Like Instem, Xybion has primarily focused on serving life...
by Instem Team | Jul 31, 2025 | Clinical, Resources
The pressure is growing on researchers and sponsors to share de-identified clinical data responsibly as global demand for clinical trial transparency continues to increase. Read this whitepaper to learn more about: The different Health Agencies’ policies Consequences...
